$12.3 million COBRE Award Announced
The Department of Microbiology & Molecular Genetics, the University of Vermont and the Larner College of Medicine are pleased to announce the receipt of a $12.3 million award for a new Center of Biomedical Research Excellence (COBRE) called the “Translational Global Infectious Disease Research Center” (TGIR). The TGIR will join together two traditionally distinct groups of scientists to develop innovative approaches to prevent and control infectious disease. The TGIR will be housed within MMG and will be led by MMG Chair and VTC Director Beth Kirkpatrick, MD, along with Chris Huston, MD and Jason Bates, PhD. Check out the news coverage at WCAX, Fox44 and WAMC Radio. Or learn more at LCOM's site or go to the TGIR website.
MMG Speaker Series: “Interspecies interactions in the gut microbiota of Drosophila: symbiosis within a symbiosis”
Presenter: Peter D. Newell, Ph.D.
Assistant Professor, SUNY Oswego
Department of Biological Sciences
Date: December 19, 2018
Place: HSRF 300
See previous MMG seminars.
TGIR COBRE Series:“Accelerating progress in global cholera control:lessons from models and field studies”
Presenter: Andrew Azman, Ph.D.
Johns Hopkins Bloomberg School of Public Health
Date: December 21, 2018
Place: HSRF 300
Vaccine Testing Center Site for New NIH Zika Vaccine Trial
Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine. The Vaccine Testing Center at the Larner College of Medicine at the University of Vermont in Burlington and Johns Hopkins Bloomberg School of Public Health Center for Immunization Research in Baltimore, Md. are the two sites where the vaccine will be tested. Learn more about the trial.